Nature Communications (Apr 2023)

MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming

  • Morgane Mabire,
  • Pushpa Hegde,
  • Adel Hammoutene,
  • Jinghong Wan,
  • Charles Caër,
  • Rola Al Sayegh,
  • Mathilde Cadoux,
  • Manon Allaire,
  • Emmanuel Weiss,
  • Tristan Thibault-Sogorb,
  • Olivier Lantz,
  • Michèle Goodhardt,
  • Valérie Paradis,
  • Pierre de la Grange,
  • Hélène Gilgenkrantz,
  • Sophie Lotersztajn

DOI
https://doi.org/10.1038/s41467-023-37453-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 13

Abstract

Read online

Liver cirrhosis is characterised by extensive fibrosis of the liver, and understanding the underpinning immunological processes is important in designing intervention. Here authors show that Mucosal-Associated Invariant T cells are instrumental to controlling the balance between profibrogenic and restorative macrophages and inhibiting their activation might reverse liver fibrosis.